Abstract| Volume 87, ISSUE 9, SUPPLEMENT , S150-S151, May 01, 2020

Chronic Lurasidone Treatment in Stress-Based Models of Psychiatric Disorders: From Prevention to Functional Normalization

      Exposure to stress in different periods of life represents a risk factor for the development of psychiatric disorders. Here we used two different experimental paradigms, the prenatal stress (PNS) model and the chronic mild stress (CMS) model to identify brain alterations caused by exposure to stress early in life or at adulthood, and to investigate the ability of the antipsychotic drug lurasidone to prevent or counteract the stress-induced abnormalities.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect